SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-035767
Filing Date
2022-12-16
Accepted
2022-12-16 16:40:58
Documents
20
Period of Report
2022-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 61910
2 ex1-1.htm EX-1.1 194691
3 ex1-2.htm EX-1.2 226680
4 ex5.htm EX-5 10219
5 ex99-1.htm EX-99.1 16013
6 ex99-2.htm EX-99.2 48912
7 ex5_001.jpg GRAPHIC 19442
8 ex99-1_001.jpg GRAPHIC 3467
  Complete submission text file 0001493152-22-035767.txt   917159

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE hrow-20221213.xsd EX-101.SCH 3941
10 XBRL DEFINITION FILE hrow-20221213_def.xml EX-101.DEF 27017
11 XBRL LABEL FILE hrow-20221213_lab.xml EX-101.LAB 37280
12 XBRL PRESENTATION FILE hrow-20221213_pre.xml EX-101.PRE 25638
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5535
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 221468482
SIC: 2834 Pharmaceutical Preparations